Cargando…
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus
OBJECTIVES: The objectives of this study were to investigate the discriminative ability of EQ-5D-3L full health state (FHS) in clinical trials of SLE, and to identify factors associated with FHS after treatment. METHODS: Data from the BLISS-52 (NCT00424476) and BLISS-76 (NCT00410384) trials of belim...
Autores principales: | Lindblom, Julius, Gomez, Alvaro, Borg, Alexander, Emamikia, Sharzad, Ladakis, Dimitris , Matilla, Joaquin, Pehr, Martin, Cobar, Flordelyn, Enman, Yvonne, Heintz, Emelie , Regardt, Malin, Parodis, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487305/ https://www.ncbi.nlm.nih.gov/pubmed/33502473 http://dx.doi.org/10.1093/rheumatology/keab080 |
Ejemplares similares
-
EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus
por: Lindblom, Julius, et al.
Publicado: (2022) -
Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State
por: Hua, Nicole, et al.
Publicado: (2023) -
Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus
por: Borg, Alexander, et al.
Publicado: (2023) -
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE
por: Borg, Alexander, et al.
Publicado: (2021) -
Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus
por: Gomez, Alvaro, et al.
Publicado: (2021)